Stran Q3 revenue $19.3M (+42% YoY), net earnings of $684K vs loss of $700K

Stran & Company, Inc.

2023-Q3 EPS reported -$0.05 vs consensus $0.01 ▼ miss (-590.2%)

Revenue $19.3M (+42% YoY); organic revenue up 30% to $15.4M; acquisitions contributed $3.9M (20.4% of sales).
Gross profit $6.4M (33% margin) vs $4.2M (31% margin) a year ago; net earnings $684K vs net loss of $700K.
Stock repurchase program: $3.4M total repurchased as of Sep 30; cash and liquid investments $19.7M.
New 3-year contract with leading medical group; loyalty redemption program generated $2M in sales from 22,000 orders in first week.
Completed integration of four acquisitions over last 18 months; focus on organic growth and selective M&A.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Stran & Company, Inc. reported three months ended September 30, 2023 results: revenue $19.3 million, net income $684,000.

Period: three months ended September 30, 2023
Revenue: $19.3 million
Net income: $684,000
Result: reported results

Exact text from the filing

we generated a 42% increase in revenue to a record $19.3 million for the third quarter of 2023. At the same time, our gross profit increased by 50% to $6.4 million, with gross profit margin increasing to 33% compared to 31% for the same period last year, and we booked net earnings of approximately $684,000.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Stran & Company, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-083655

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.